LFCR FY 2019 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$558M+6.4% YoY

Gross Profit

$81M14.5% margin

Operating Income

-$8M-1.4% margin

Net Income

$2M0.4% margin

EPS (Diluted)

$0.07

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

-$29M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$519M

Total Liabilities

$249M

Stockholders' Equity

$270M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$558M	$524M	+6.4%
Gross Profit	$81M	$78M	+3.4%
Operating Income	-$8M	$12M	-167.6%
Net Income	$2M	$25M	-91.5%